Vestal Point Capital »

West Pharmaceutical Services shares owned by Vestal Point Capital

Quarter-by-quarter ownership of West Pharmaceutical Services (WST) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in West Pharmaceutical Services

Tip: Access up to 7 years of quarterly data

All positions including West Pharmaceutical Services held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in West Pharmaceutical Services by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $19M 75k 250.64

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding West Pharmaceutical Services

Vanguard Group
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Artisan Partners Limited Partnership
Bank of New York Mellon
Generation Investment Management
Geode Capital Management
Morgan Stanley
Brown Advisory Holdings Incorporated
Longview Partners
APG All Pensions Group NV
T. Rowe Price Investment Management
Invesco

View all funds holding West Pharmaceutical Services